CareFusion

• Billionaire David Einhorn’s Long-Term Stock Picks

  By Meena Krishnamsetty - July 24, 2012 | Tickers: AAPL, CFN, ESV, MSFT, NCR

  David Einhorn’s Greenlight Capital is a long/short value-oriented hedge fund whose success over the past 16 years has recently put him over the $1 billion net worth mark. He has famously short sold companies such as Allied Capital, Lehman Brothers, and Green Mountain Coffee Roasters when he believed they were overvalued. Einhorn reports his long positions in US stocks in 13F filings as other hedge funds do (see more »

• Targeting Medtech Stocks

  By Streetwise Reports - March 19, 2012 | Tickers: ARTC, CFN, COV, MDT, STJ

  George S. Mack, The Life Sciences Report
  
  I recently had an interesting conversation with BMO Capital Markets Managing Director Joanne Wuensch. She's a medical technology analyst who understands the forces creating demand as well as those that are depressing innovation in new technology. People have an interest in technology stocks because these innovative companies represent an opportunity for growth. That's been true since the invention of the wheel more »

• Hold Off On Hospira

  By Justin Carley - February 14, 2012 | Tickers: BAX, CFN, HSP |

  Hospira (NYSE: HSP) reported 4Q11 results this morning and shares are up more than 6% as the session nears an end.  The results were awful thanks to a terrible 2011 that was highlighted by FDA warning letters and plant shutdowns.  Actual earnings-per-share for the fourth quarter was -$1.30 due to plant shutdowns and other remediation costs.  So what has the shares moving higher?  First off, the key plant in more »

• Price The Market Part 37

  By Glen Bradford - January 10, 2012 | Tickers: BSX, CAH, CFN, CELG, CERN

  Boston Scientific (NYSE: BSX) is bottoming. Target: $6-$7. Now is a good time to buy.

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)